International Psoriasis Council

Advancing Knowledge. Improving Care.

Marcus Schmitt-Egenolf

Marcus

Schmitt-Egenolf

,

MD, PhD

Professor of dermatovenereology & distinguished teacher, Department of public health & clinical medicine
Umeå University
Umea
,
Sweden
Councilor Since: September 1, 2018
IPC Councilor
Professor Marcus Schmitt-Egenolf is a Professer of Dermatology at Umeå University and an affiliated researcher at Karolinska Institute, Sweden. He studied in Frankfurt, Vienna, and Edmonton. After his MD-thesis (psoriasis-immunogenetics) under the guidance of Enno Christophers and Wolfram Sterry, the German Research Council funded his postdoctoral research with Georg Stingl in Vienna. After that, he became a specialist at the Charité, Berlin. Following his PhD, he became an associate professor in 2000 at the Norwegian University of Science and Technology (NTNU), Trondheim. Since 2002 he has worked in Umeå, where he was appointed head of dermatovenereology in 2012, then full professor and distinguished teacher in 2014.

Marcus’ research centers on melanoma and psoriasis. He initiated the Swedish psoriasis registry in 2006 and is part of the editorial boards of several journals and associate editor at the British Journal of Dermatology. Marcus is a member of the IPC’s psoriasis severity working group, a responsible dermatologist for the national psoriasis guidelines from the Swedish Board of Health and Welfare, and a senior advisor for several other public agencies and organizations.
Last Updated:
04/04/2022

Areas of Interest

Real world evidence.

IPC Committees / Groups

Disease Severity Working Group

Languages Spoken

English, German, Norwegian, Swedish

Involvement with Other Organization(s)

Member of the Scientific Advisory Board Swedish patient organisation PSO; responsible dermatologist in the project management for the national guidelines for psoriasis at the Swedish Board of Health and Welfare; Senior advisor at Swedish Board of Health and Welfare (SoS), Swedish Agency for Health Technology Assessment (SBU), Medical Products Agency (MPA), and Swedish Dental and Pharmaceutical Benefits Agency (TLV).

What's New

Use and Misuse of Systemic Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.

WATCH NOW

Thursday, May 14, 2026

Use and Misuse of Topical Corticosteroids in Psoriasis

In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.

WATCH NOW

Thursday, May 14, 2026

Videos Now Available from the IEC & IPC Joint Symposium at AAD

Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.

WATCH NOW

Wednesday, May 27, 2026